The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix
- PMID: 33888337
- DOI: 10.1016/j.ygyno.2021.04.019
The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix
Abstract
Objective: Small cell neuroendocrine carcinoma of the cervix (SCNEC) is a lethal malignancy and little treatment progress has been made for decades. We sought to map its genetic profiles, and identify whether SCNEC harbor mutations and potential targets for therapeutic interventions.
Methods: Primary tumor tissue and blood samples were obtained from 51 patients with SCNEC. The next-generation sequencing was carried out to detect mutations of 520 cancer-related genes, including the entire exon regions of 312 genes and the hotspot mutation regions of 208 genes. Quantitative multiplex PCR was performed for the detection of seven high-risk HPV types.
Results: Of the 51 detected patients, 92.16% were positive for HPV 18. Ninety-eight percent of cases harbored genetic alterations. Two cases were observed with hypermutated phenotype and determined as MSI-H/dMMR. Genetic mutations were clustering in RTK/RAS(42.86%), PI3K-AKT(38.78%), p53 pathway(22.45%) and MYC family(20.41%). Mutations in genes involved in the p53 pathway indicate a poorer prognosis (3-year OS, 33.5% vs 59.9%, p = 0.031). A total of seven patients harboring mutations in homogeneous recombination repair (HRR) genes were reported. In addition, IRS2 and SOX2 were amplified in 14.9% and 6.12% of SCNEC patients, respectively.
Conclusions: SCNEC is specifically associated with HPV 18 infection. Its genetic alterations are characterized by a combined feature of high-risk HPV driven events and mutations observed in common neuroendocrine carcinoma. We identified several targetable mutated genes, including KRAS, PIK3CA, IRS2, SOX2, and HRR genes, indicating the potential efficacy of target therapies in these patients. MSI-H/dMMR individuals may benefit from checkpoint blockade therapies.
Keywords: HPV; Mutations; Next-generation sequencing; Small cell neuroendocrine carcinoma; Uterine cervix.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors report no conflict of interest.
Similar articles
-
Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.Am J Surg Pathol. 2018 Jun;42(6):750-760. doi: 10.1097/PAS.0000000000001042. Am J Surg Pathol. 2018. PMID: 29505425 Free PMC article.
-
Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.BMC Cancer. 2021 Mar 31;21(1):332. doi: 10.1186/s12885-021-08059-1. BMC Cancer. 2021. PMID: 33789601 Free PMC article.
-
Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.J Pathol. 2024 Jul;263(3):372-385. doi: 10.1002/path.6290. Epub 2024 May 9. J Pathol. 2024. PMID: 38721894
-
Clinicopathological characteristics and outcome of patients with small cell neuroendocrine carcinoma of the uterine cervix: case series and literature review.Eur J Gynaecol Oncol. 2013;34(4):307-10. Eur J Gynaecol Oncol. 2013. PMID: 24020135 Review.
-
Imaging and staging of neuroendocrine cervical cancer.Abdom Radiol (NY). 2018 Dec;43(12):3468-3478. doi: 10.1007/s00261-018-1667-0. Abdom Radiol (NY). 2018. PMID: 29974177 Review.
Cited by
-
Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies Ahead.J Pers Med. 2024 Apr 27;14(5):462. doi: 10.3390/jpm14050462. J Pers Med. 2024. PMID: 38793044 Free PMC article. Review.
-
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2321898121. doi: 10.1073/pnas.2321898121. Epub 2024 Apr 16. Proc Natl Acad Sci U S A. 2024. PMID: 38625939
-
Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.Clin Cancer Res. 2024 May 1;30(9):1846-1858. doi: 10.1158/1078-0432.CCR-23-2360. Clin Cancer Res. 2024. PMID: 38180245 Free PMC article.
-
Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker.Cancer Cell Int. 2023 Dec 18;23(1):329. doi: 10.1186/s12935-023-03132-0. Cancer Cell Int. 2023. PMID: 38110977 Free PMC article. Review.
-
Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.Curr Oncol. 2023 Oct 24;30(11):9428-9436. doi: 10.3390/curroncol30110682. Curr Oncol. 2023. PMID: 37999102 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous